History of the ABMGG

Incorporated in 1980, the American Board of Medical Genetics and Genomics certifies individuals in the field of human genetics.

The establishment of the American Board of Medical Genetics and Genomics evolved out of a recognized need and commitment by the founding members to improve the level and standards of clinical care in the area of medical genetics, both for the care giver and the institutions providing care. It was also apparent that within this rapidly expanding field, specific areas of expertise were emerging, all equally important components of the clinical genetics health care delivery system. Thus, a twelve-member Board of Directors was founded consisting of human geneticists representing expertise in the areas of clinical genetics, medical genetics, laboratory genetics (including clinical cytogenetics, clinical biochemical and clinical molecular genetics) and genetic counseling.

ABMGG Past Presidents & Board Chairs
Dr. David Rimoin,
President, 1980-1983
Dr. OJ Miller,
President, 1984-1985
Dr. Walter Nance,
President, 1986-1987
Dr. C. Ronald Scott,
President, 1988
Dr. Larry Shapiro,
President, 1989
Dr. Charles Epstein,
President, 1990-1991
Dr. M. Anne Spence,
President, 1992
Dr. Thaddeus Kelly,
President, 1993-1994
Dr. Edward McCade,
President, 1995-1996
Dr. Peter Byers,
President, 1997
Dr. Daniel Van Dyke,
President, 1998-1999
Dr. Haig Kazazian,
President, 2000
Dr. Miriam Blitzer,
President, 2001
Dr. Roberta Pagon,
President, 2002-2003
Dr. Nancy Carpenter,
President, 2004
Dr. Georgia Wiesner,
President, 2005
Dr. Nancy Carpenter,
President, 2006
Dr. Stuart Schwartz,
President, 2007
Dr. Cynthia Moore,
President, 2008
Dr. Charles Schwartz,
President, 2009
Dr. Christopher
Cunniff,
President, 2010
Dr. Tina Cowan,
President, 2011
Dr. Cynthia Powell,
President, 2012
Dr. Athena Cherry,
President, 2013
Dr. Laurie Demmer,
President, 2015
Dr. V. Reid Sutton,
Chair, 2016-2017
Dr. Ayesha Ahmad,
Chair, 2018-2019
Dr. Azra Ligon,
Chair, 2020-2021
Dr. Anne Slavotinek,
Chair, 2022
Dr. Katrina Dipple,
Chair, 2023-2025
Current: Dr. Peter Hulick,
Chair, 2026-

To reinforce its commitment to quality care at the individual level, the Board, with the assistance of the National Board of Medical Examiners, instituted certifying examinations in these areas of expertise. These certifying examinations are offered annually (with the exception of Clinical & Medical Biochemical Genetics which is administered every two years).  In order to be eligible to sit for the examination, the candidate must have successfully completed a minimum of two years in an ACGME-accredited training program. Individuals who want to sit for clinical genetics and genomics and a laboratory specialty must complete a minimum of three years in an ACGME-accredited training program (see training options).

In order to ensure that state-of-the-art techniques, standards and practices are being met at the institutional level, a stringent process of accreditation has been made available to programs that train medical genetics personnel in the areas of clinical and laboratory medicine. The Residency Review Committee (RRC) for the American Council of Graduate Medical Education (ACGME) accredits both clinical and laboratory training programs.

ABMGG Timeline

1981

First Certification Exam Administered

Began certifying medical geneticists — clinical geneticists, clinical laboratory geneticists (cytogenetics and biochemical genetics), and PhD medical geneticists — with specialized education and clinical skills.

1980s

Program Accreditation Begins

ABMGG begins accrediting medical genetics training programs.

1991

Accepted by the ABMS

ABMGG is accepted by the American Board of Medical Specialties as the newest (24th) member specialty board.

1990s

Accreditation Roles Take Shape

ACGME begins to accredit residency programs, while ABMGG continues to accredit lab training programs.

1993

Clinical Molecular Genetics Specialty

A new specialty in Clinical Molecular Genetics is approved.

1999

Joint Subspecialty in Molecular Genetic Pathology

Established jointly with the American Board of Pathology.

2005

Biennial Examinations

Certifying exams move from every three years to every two years.

2007

Medical Biochemical Genetics

A new subspecialty in Medical Biochemical Genetics is approved.

2014

Name Change

The board is renamed the American Board of Medical Genetics and Genomics.

2016

Laboratory Genetics and Genomics

A new specialty in Laboratory Genetics and Genomics is approved.

2017

Accreditation Transition Approved

ABMGG and ACGME Board of Directors transitioning lab training program accreditation to ACGME.

2018

Transition to Continuing Certification

Begins moving away from 10-year time-limited certificates to ongoing Continuing Certification requirements.

2024

New ABMS Continuing Certification Standards

Adopted across all ABMS member boards.

2025

Annual Certifying Exams

Certification exams transition to an annual cycle.

ABMS and the specialty boards are accountable both to the public and the medical profession through:

  • Helping Patients by providing information about the board certification process and which doctors are board certified.
  • Supporting Physicians by creating programs that assist doctors in staying current in their field and improve their practice.
  • Collaborating with Healthcare Leaders to foster initiatives for the promotion and monitoring of healthcare quality.
  • Transforming Healthcare by increasing awareness of the importance of board certification and lifelong learning in assuring quality care.